Announce Date | 04/24/2025 |
EPS Normalized Actual | $0.02 (Beat by $0.01) |
EPS GAAP Actual | $0.02 (Beat by $0.01) |
Revenue Actual | $1.268B |
Revenue Surprise | Beat by $1268M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.070705 |
EPS GAAP Estimate | $0.070705 |
Revenue Estimate | $1.348492719B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 0.32 | 13.84 | 0.31036 | 0.33682 | 1 |
Dec 2026 | 0.1945 | 22.78 | 0.18 | 0.209 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.02 | -0.02 | 1.268B | 10.02% | 1268M |
FQ4 2024 (Dec 2024) | 0 | 0 | 1.195B | 5.27% | 1195M |
FQ3 2024 (Sep 2024) | 0.0201 | 0.0201 | 1.313B | 1.45% | 1313M |
FQ1 2020 (Mar 2020) | -0.0051 | -0.0051 | 0.8295B | 100% | 829.5M |
FQ2 2024 (Jun 2024) | 0.0033 | 0.0033 | 1.259B | 0.32% | 1259M |
FQ1 2024 (Mar 2024) | -0.0201 | -0.0201 | 1.141B | 0.88% | 1141M |
FQ4 2023 (Dec 2023) | -0.0938 | -0.0938 | 1.132B | 4.95% | 1132M |
FQ3 2023 (Sep 2023) | 0.02 | 0.02 | 1.294B | 100% | 1294M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.070705
Consensus Revenue Estimates
1.348492719B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.04865 | -- | 0.04738942 | 0.05108932 | 1 |
FQ3 2027 (Sep 2027) | 0.092519 | -- | 0.09012173 | 0.09715791 | 1 |
FQ2 2027 (Jun 2027) | 0.083719 | -- | 0.08154975 | 0.08791668 | 1 |
FQ1 2027 (Mar 2027) | 0.031685 | -- | 0.03086401 | 0.03327369 | 1 |
FQ4 2026 (Oct 2026) | 0.11358 | -- | 0.11186 | 0.11505 | 1 |
FQ3 2026 (Jul 2026) | 0.090609 | -- | 0.08923504 | 0.09178497 | 1 |
FQ2 2026 (Jun 2026) | 0.089122 | -- | 0.08740973 | 0.0908067 | 1 |
FQ1 2026 (Mar 2026) | 0.025544 | 178.3 | 0.02497667 | 0.02657591 | 3 |
FQ4 2025 (Oct 2025) | 0.089387 | -- | 0.08803157 | 0.09054711 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.27B | -- | 1.24B | 1.32B | 1 |
FQ3 2027 (Sep 2027) | 1.39B | -- | 1.36B | 1.44B | 1 |
FQ2 2027 (Jun 2027) | 1.33B | -- | 1.31B | 1.38B | 1 |
FQ1 2027 (Mar 2027) | 1.21B | -- | 1.18B | 1.25B | 1 |
FQ4 2026 (Oct 2026) | 1.43B | -- | 1.41B | 1.44B | 1 |
FQ3 2026 (Jul 2026) | 1.38B | -- | 1.37B | 1.4B | 1 |
FQ2 2026 (Jun 2026) | 1.34B | -- | 1.32B | 1.36B | 1 |
FQ1 2026 (Mar 2026) | 1.2B | -5.61 | 1.18B | 1.24B | 2 |
FQ4 2025 (Oct 2025) | 1.39B | 13.98 | 1.37B | 1.4B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
4
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.02 | -0.02 | 100% | |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 0.0201 | 0.0201 | 100% | |
FQ1 2020 (Mar 2020) | -0.0051 | -0.0051 | 100% | |
FQ2 2024 (Jun 2024) | 0.0033 | 0.0033 | 100% | |
FQ1 2024 (Mar 2024) | -0.0201 | -0.0201 | 100% | |
FQ4 2023 (Dec 2023) | -0.0938 | -0.0938 | 100% | |
FQ3 2023 (Sep 2023) | 0.02 | 0.02 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.27B | $1268M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.2B | $1195M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.31B | $1313M | 100% |
FQ1 2020 (Mar 2020) | $0B | $0.83B | $829.5M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.26B | $1259M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.14B | $1141M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.13B | $1132M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.29B | $1294M | 100% |